Dolutegravir/lamivudine/tenofovir (Viropil, DTG/3TC/TDF) Chinese instructions
Drug name: Dolutegravir/Lamivudine/Tenofovir (Viropil, Viropil, DTG/3TC/TDF)
Indications: Dolutegravir/Lamivudine/Tenofovir is a drug used to treat human immunodeficiency virus (HIV) infection. It is suitable for HIV-infected persons aged 12 years or older and weighing at least 35kg.
Mechanism of action: Dolutegravir belongs to the integrase chain terminator drug class and can preventHIV from integrating its viral genetic material into the host cellDNA. Lamivudine and tenofovir are nucleoside analog reverse transcriptase inhibitors that can prevent the reverse transcription process of HIV and thereby inhibit viral replication.
Pharmacology: Dolutegravir/Lamivudine/The combination of tenofovir interferes with the different replication steps of HIV and reduces the virus's ability to reproduce in the patient's body, thereby controlling the number of viruses and maintaining immune system function.
Dosage and usage: The common usage is to take it orally once a day. Dosage may vary between individuals and should be used accurately according to your doctor's recommendations.
Side effects: Common side effects may include nausea, vomiting, diarrhea, headache, etc. Serious side effects may include abnormal liver function, lactic acidosis, allergic skin reactions, etc. Any discomfort or abnormal reaction should be reported to the doctor promptly.

Warnings and Precautions:
1.Only used for HIV infection treatment, not for other viral infections.
2.Patients need to regularly monitor liver function, kidney function, lactic acidosis and other indicators.
3.Pregnant or lactating women should use it under the guidance of a doctor to avoid potential risks.
4.It is strictly prohibited to consult a doctor or pharmacist before using it with other drugs to avoid drug interactions.
Contraindications:
1.Those who are allergic to any ingredients in this medicine.
2.There are serious drug interactions with some specific drugs (such as Gracivir, Botenib, Nefavir, etc.).
Drug interactions:
1.Before using this medication, be sure to tell your doctor about any other medications you are taking, including prescription drugs, over-the-counter drugs, and supplements.
2.This drug may interact with other drugs, which may affect its efficacy or increase the risk of side effects.
Medication for special groups: Special groups such as children, the elderly, pregnant women, and lactating women should use it under the guidance of a doctor, because the medication may have different effects on them.
Launching and price status: dolutegravir/lamivudine/tenofovir (Veramp,
This information is an overview only. For specific medication information, please refer to the latest drug instructions and consult a professional doctor before use. If you have any questions, discomfort, or side effects while taking this medication, please contact a medical professional immediately.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)